fatigue on glp 1 Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? ⁣ ⁣ A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype Stopped Loosing weight on a

In the trial of approximately 1,200 participants with type 2 diabetes and a body mass index (BMI) of 27 or higher, those treated with CagriSema achieved a weight loss of 15.7% after 68 weeks compared to 3.1% with placebo

For employers, these findings suggest that evaluating GLP-1s solely through pharmacy spend may overlook broader impacts on overall healthcare costs and workforce health

Epithalon Key Health Benefits: Anti-aging benefits by stimulating telomerase Improved sleep quality Immune system support Antioxidant properties Potential cancer prevention Need supplies

Valent P, Akin C, Bonadonna P, et al

Quindi potrebbe favorire la perdita di peso, aumentando il dispendio calorico

Cost Impacts to Health Plans Rising Pharmacy Costs: Health plans could face a 20%35% increase in overall pharmacy spending for members with diabetes or obesity